Authors:
Fleming, GF
Fowler, JM
Waggoner, SE
Copeland, LJ
Greer, BE
Horowitz, I
Sutton, G
Schilder, RJ
Fracasso, PM
Ball, HG
McGuire, WP
Citation: Gf. Fleming et al., Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: A Gynecologic Oncology Group Study, J CL ONCOL, 19(4), 2001, pp. 1021-1029
Authors:
Mundt, AJ
McBride, R
Rotmensch, J
Waggoner, SE
Yamada, SD
Connell, PP
Citation: Aj. Mundt et al., Significant pelvic recurrence in high-risk pathologic stage I-IV endometrial carcinoma patients after adjuvant chemotherapy alone: Implications for adjuvant radiation therapy, INT J RAD O, 50(5), 2001, pp. 1145-1153
Authors:
Mundt, AJ
Murphy, KT
Rotmensch, J
Waggoner, SE
Yamada, SD
Connell, PP
Citation: Aj. Mundt et al., Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrialcarcinoma, INT J RAD O, 50(5), 2001, pp. 1154-1160
Authors:
Fleming, GF
Waggoner, SE
Rotmensch, J
Langhauser, C
Citation: Gf. Fleming et al., Absence of major peripheral neuropathy in a phase II trial of ifosfamide with vinorelbine in patients with ovarian cancer previously treated with platinum and paclitaxel, AM J CL ONC, 24(1), 2001, pp. 52-57
Authors:
Prokopczyk, B
Trushin, N
Leszczynska, J
Waggoner, SE
El-Bayoumy, K
Citation: B. Prokopczyk et al., Human cervical tissue metabolizes the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, via a-hydroxylation and carbonyl reduction pathways, CARCINOGENE, 22(1), 2001, pp. 107-114
Authors:
Mundt, AJ
Roeske, JC
Lujan, AE
Yamada, SD
Waggoner, SE
Fleming, G
Rotmensch, J
Citation: Aj. Mundt et al., Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies, GYNECOL ONC, 82(3), 2001, pp. 456-463
Authors:
Mundt, AJ
Rotmensch, J
Waggoner, SE
Yamada, D
Langhauser, C
Fleming, GF
Citation: Aj. Mundt et al., Phase I trial of concomitant vinorelbine, paclitaxel, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies, GYNECOL ONC, 82(2), 2001, pp. 333-337
Authors:
Roeske, JC
Lujan, A
Rotmensch, J
Waggoner, SE
Yamada, D
Mundt, AJ
Citation: Jc. Roeske et al., Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies, INT J RAD O, 48(5), 2000, pp. 1613-1621
Authors:
Rotmensch, J
Connell, PP
Yamada, D
Waggoner, SE
Mundt, AJ
Citation: J. Rotmensch et al., One versus two intracavitary brachytherapy applications in early-stage cervical cancer patients undergoing definitive radiation therapy, GYNECOL ONC, 78(1), 2000, pp. 32-38
Authors:
Matthews, AK
Aikens, JE
Helmrich, SP
Anderson, DD
Herbst, AL
Waggoner, SE
Citation: Ak. Matthews et al., Sexual functioning and mood among long-term survivors of clear-cell adenocarcinoma of the vagina or cervix, J PSYCH ONC, 17(3-4), 1999, pp. 27-45